Ruilope L M, García-Robles R
Hypertension Unit, Hospital 12 de Octubre, Madrid, Spain.
J Hypertens Suppl. 1998 Jan;16(1):S91-3.
Diabetes mellitus and arterial hypertension are closely related and strongly predispose an individual to atherosclerosis and renal failure. Hypertension is twice as frequent in diabetic individuals as it is in the general population, and often precedes the development of diabetic nephropathy. The prevalence of coexisting arterial hypertension and non-insulin-dependent diabetes mellitus is increasing because of ageing of the population, allowing an augmented prevalence of atherosclerosis and end-stage diabetic renal disease. ANTIHYPERTENSIVE TREATMENT OF DIABETIC PATIENTS: The goal of blood pressure control in diabetic patients is to reduce death and disability as much as possible. In addition, other reversible risk factors for cardiovascular disease, which are so frequently seen in hypertensive diabetic individuals, need to be addressed. The optimal blood pressure level in diabetic individuals has not yet been established, but it has been suggested that it be should lower than that recommended by current guidelines. In fact, the literature indicates that 130/85 mmHg should be the systolic/diastolic blood pressure goal in hypertensive diabetic individuals. According to most guidelines the threshold for intervention when multiple associated risk factors coexist with hypertension is a blood pressure level 140/90 mmHg. In diabetic patients therapy has to be instituted early and aggressively. In this regard, angiotensin converting enzyme inhibitors alone or in association with other drugs seem to be the best choice for hypertensive diabetic patients.
糖尿病和动脉高血压密切相关,会使个体极易患动脉粥样硬化和肾衰竭。糖尿病患者中高血压的发病率是普通人群的两倍,且往往先于糖尿病肾病出现。由于人口老龄化,并存动脉高血压和非胰岛素依赖型糖尿病的患病率正在上升,这使得动脉粥样硬化和终末期糖尿病肾病的患病率增加。糖尿病患者的抗高血压治疗:糖尿病患者血压控制的目标是尽可能降低死亡和残疾风险。此外,高血压糖尿病患者中常见的其他心血管疾病可逆风险因素也需要得到解决。糖尿病患者的最佳血压水平尚未确定,但有人建议应低于当前指南推荐的水平。事实上,文献表明,高血压糖尿病患者的收缩压/舒张压目标应为130/85 mmHg。根据大多数指南,当多种相关风险因素与高血压并存时,干预阈值为血压水平140/90 mmHg。糖尿病患者必须尽早积极进行治疗。在这方面,单独使用血管紧张素转换酶抑制剂或与其他药物联合使用似乎是高血压糖尿病患者的最佳选择。